Rev Med UAS
Vol. 10: No. 4. Octubre-Diciembre 2020
ISSN 2007-8013

Conocimiento de fisioterapeutas mexicanos respecto a la fibromialgia y su tratamiento no farmacológico

Knowledge of Mexican physiotherapists regarding fibromyalgia and its non -pharmacological treatment

Adriana Cruz-Bañares1*, Claire Diver1p

1Division of Physiotherapy and Rehabilitation Sciences, University of Nottingham, Nottingham, UK

*Autor corresponsal: Adriana Cruz–Bañares
Dirección: Av. Valle del Campanario #128.
Fracc. Valle del Campanario. C.P. 20100. Aguascalientes, Ags. México.

DOI http://dx.doi.org/10.28960/revmeduas.2007-8013.v10.n4.002

Texto Completo PDF

Recibido 27 de Septiembre 2020, aceptado 27 de Octubre 2020

RESUMEN
Antecedentes: La fibromialgia es una patología compleja caracterizada principalmente por dolor generalizado y fatiga; su complejidad dificulta su diagnóstico y tratamiento multidisciplinario. Es comúnmente asociada a un conocimiento limitado entre profesionales de la salud. --- Objetivo: evaluar el conocimiento que fisioterapeutas mexicanos tienen respecto a la Fibromialgia y su tratamiento no farmacológico basado en la evidencia. --- Materiales y Métodos: se realizó un estudio transversal aplicando un cuestionario cuantitativo a fisioterapeutas Mexicanos para evaluar su conocimiento respecto a la patología, sintomatología, diagnóstico y tratamiento de la fibromialgia. --- Resultados:La muestra incluyó 97/405 fisioterapeutas egresados. El estudio reveló que 73% de los participantes contaban con experiencia previa con pacientes con Fibromialgia; el dolor difuso (90%) y sueño no efectivo (78%), se identificaron como los principales síntomas. La consulta médica y el examen físico se consideraron como los medios diagnósticos más frecuentes (73%); el ejercicio físico y los antidepresivos fueron considerados la mejor combinación terapéutica (73%). El 81% expresó que la actividad física puede mejorar la salud del paciente. Finalmente, más de la mitad de los participantes (55%) enunció no conocer las guías clínicas nacionales y el 69% no estar familiarizado con ninguna guía nacional o internacional. --- Conclusiones: El conocimiento de fisioterapeutas mexicanos respecto a la fibromialgia es inconsistente con las guías clínicas actuales. La mejora de los programas formativos en relación al conocimiento y uso de guías clínicas puede mejorar el manejo de pacientes con Fibromialgia.
Palabras clave: Fibromialgia; Estudio Transversal; Fisioterapeutas; México

ABSTRACT
Knowledge of Mexican physiotherapists regarding fibromyalgia and its non -pharmacological treatment
Background: Fibromyalgia is a complex condition primarily characterized by widespread pain and fatigue; its complexity makes its diagnosis and multidisciplinary treatment difficult. This is commonly associated with poor knowledge amongst health care professionals. --- Objective: To assess the specific knowledge about fibromyalgia and its non-pharmacological treatment among Mexican physiotherapists. --- Methods and Materials: a cross-sectional study of Mexican physiotherapists was conducted utilizing a quantitative questionnaire to assess their knowledge about Fibromyalgia symptoms, diagnosis and treatment. --- Results: The sample included 97/405 registered physiotherapists. 73% of responding participants had previous experience treating patients with Fibromyalgia; diffuse pain (90%) and restless sleep (78%), were identified as the main symptoms. The most common method of diagnosis was consultation including physical examination by a medical Practitioner (73%); physical exercise and antidepressants were considered the optimum treatment combination (73%). 81% expressed that physical activity can improve patient well-being. More than half of the participants (55%) were unfamiliar with the national Mexican clinical guideline, and 69% were unfamiliar with any national or international guidelines. --- Conclusions: The knowledge of fibromyalgia among Mexican physiotherapists is inconsistent with current best practice guidelines. Education of physiotherapists regarding awareness and utilization of clinical guidelines could improve management of patients with Fibromyalgia.
Key words: Fibromyalgia; Cross-sectional study; Physiotherapists; Mexico

Referencias

  1. Chinn S, Caldwell W, Gritsenko K. Fibromyalgia Pathogenesis and Treatment Options Update. Curr Pain Headache Rep. 2016;20(4):25.
  2. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356.
  3. Clark P. Frecuencias y características de la fibromialgia en el Hospital General de México: revisión de la Epidemiología. Rev Mex Reumatol 2001;16:191-7.
  4. Bidari A, Ghavidel Parsa B, Ghalehbaghi B. Challenges in fibromyalgia diagnosis: from meaning of symptoms to fibromyalgia labeling. Korean J Pain. 2018;31(3):147-54.
  5. Sumpton JE, Moulin DE. Fibromyalgia. Handb Clin Neurol. 2014;119:513-27.
  6. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600-10.
  7. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319-29.
  8. Abeles M, Solitar BM, Pillinger MH, Abeles AM. Update on fibromyalgia therapy. Am J Med. 2008;121(7):555-61.
  9. Walitt B, Klose P, Fitzcharles MA, Phillips T, Häuser W. Cannabinoids for fibromyalgia. Cochrane Database Syst Rev. 2016;7:CD011694.
  10. Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-28.
  11. Pronovost PJ. Enhancing physicians' use of clinical guidelines. JAMA. 2013;310(23):2501-2.
  12. Guerrero Montenegro VJ, López Roldan V, Mejía Holguín Y, Parrilla Ortiz JI, Perez Rojas A, Ramos Garzón E, et al. Guía de Practica Clínica. Diagnóstico Y Tratamiento de Fibromialgia en el adulto. In: Salud Sd, editor. Mexico, DF: CENETEC; 2009.
  13. Acuña Ortiz FE, Capitán de la Cruz VA, León Jiménez FE. Knowledge on fibromyalgia among general practitioners, from Chiclayo-Peru, 2016. Reumatol Clin. 2017;13(6):326-30.
  14. Kaki AM, Hazazi AA. Assessment of medical practitioners' knowledge of fibromyalgia in Saudi Arabia. Saudi J Anaesth. 2018;12(2):178-82.
  15. Gómez IJQ, Ortiz AS, Barrientos JR. Frecuencia de la fibromialgia primaria, secundaria y patologías asociadas, en el Servicio de Medicina de Rehabilitación del Hospital Regional 1 de Octubre del ISSSTE. Rev Mex Med Fis Rehab. 2009;21:49-55.
  16. Colmenares-Roa T, Huerta-Sil G, Infante-Castañeda C, Lino-Pérez L, Alvarez-Hernández E, Peláez-Ballestas I. Doctor-Patient Relationship Between Individuals With Fibromyalgia and Rheumatologists in Public and Private Health Care in Mexico. Qual Health Res. 2016;26(12):1674-88.
  17. Perrot S, Choy E, Petersel D, Ginovker A, Kramer E. Survey of physician experiences and perceptions about the diagnosis and treatment of fibromyalgia. BMC Health Serv Res. 2012;12:356.
  18. Suda AL, Jennings F, Bueno VC, Natour J. Development and validation of Fibromyalgia Knowledge Questionnaire: FKQ. Rheumatol Int. 2012;32(3):655-62.
  19. International statistical classification of disease and related problems. ICD-10 [Internet]. 1992.
  20. Kamoun S, Elleuch M, Le Lay K, Feki H, Taieb C, André E, et al. [Evaluation of knowledge of fibromyalgia in Tunisia]. Tunis Med. 2010;88(10):703-6.
  21. Arnold LM, Clauw DJ. Challenges of implementing fibromyalgia treatment guidelines in current clinical practice. Postgrad Med. 2017;129(7):709-14.
  22. Barth JH, Misra S, Aakre KM, Langlois MR, Watine J, Twomey PJ, et al. Why are clinical practice guidelines not followed? Clin Chem Lab Med. 2016;54(7):1133-9.
  23. Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evid Based Med. 2016;21(4):125-7.
  24. Moretti FA, Heymann RE, Marvulle V, Pollak DF, Riera R. Assessing knowledge on fibromyalgia among Internet users. Rev Bras Reumatol. 2011;51(1):7-19.
  25. Thorne SE, Harris SR, Mahoney K, Con A, McGuinness L. The context of health care communication in chronic illness. Patient Educ Couns. 2004;54(3):299-306.
  26. Liu PH, Landrum MB, Weeks JC, Huskamp HA, Kahn KL, He Y, et al. Physicians' propensity to discuss prognosis is associated with patients' awareness of prognosis for metastatic cancers. J Palliat Med. 2014;17(6):673-82.
  27. Francke AL, Smit MC, de Veer AJ, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak. 2008;8:38.